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OBJECTIVE — The widespread clinical application of continuous glucose monitoring
(CGM) is limited by the lack of generally accepted reference values. This multicenter study aims
to establish preliminary normal reference values for CGM parameters in a sample of healthy
Chinese subjects.
RESEARCH DESIGN AND METHODS — A total of 434 healthy individuals with
normalglucoseregulationcompleteda3-dayperiodofglucosemonitoringusingaCGMsystem.
The 24-h mean blood glucose (24-h MBG) and the percentage of time that subjects’ blood
glucose levels were 140 mg/dl (PT140) and 70 mg/dl (PT70) within 24 h were analyzed.
RESULTS — There was excellent compliance of ﬁnger stick blood glucose values with CGM
measurementsforsubjects.Amongthe434subjects,thedailybloodglucosevariedfrom76.9
11.3 to 144.2  23.2 mg/dl. The 24-h MBG, PT140, and PT70 were 104  10 mg/dl, 4.1 
5.8%, and 2.4  5.3%, respectively. As for these parameters, no signiﬁcant differences were
found between men and women. The 95th percentile values were adopted as the upper limits of
CGM parameters, which revealed 119 mg/dl (6.6 mmol/l) for 24-h MBG, 17.1% for PT140, and
11.7% for PT70.
CONCLUSIONS — We recommend a 24-h MBG value 119 mg/dl, PT140 17% (4 h),
and PT70 12% (3 h) as normal ranges for the Chinese population.
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G
lucose monitoring is a key compo-
nent in diabetes management.
Monitoringresultscanbeusedclin-
icallyindeterminingthedegreeofglucose
metabolic disturbance, evaluating thera-
peutic outcomes, and guiding the adjust-
ment of treatment regimens (1).
Compared with traditional monitoring
methods, the recently developed contin-
uous glucose monitoring (CGM) tech-
nique provides much more glycemic
information, including magnitude, dura-
tion, and frequency of blood glucose lev-
els,whichisusedtobetterunderstandthe
properties of shifting blood glucose levels
throughout the day. Although some
drawbacks exist, CGM is able to reveal
hyperglycemia and asymptomatic hypo-
glycemia that are normally difﬁcult to de-
tect, so as to provide evidence for optimal
treatment decisions (2–4). The extensive
data obtained from CGM could further
characterize the blood glucose proﬁles in
patients with diabetes (5). With its capa-
bility of recording blood glucose ﬂuctua-
tions, CGM also represents a new tool for
studying the inﬂuence of factors on glu-
cose variations in real life (6). Thus, ap-
plications of CGM continue to expand in
both clinical practice and research set-
tings. However, few investigations of
blood glucose proﬁles in the population
without diabetes have been performed
using CGM. Moreover, there remains a
paucity of reference data reﬂecting the
typical daily patterns and proﬁles of nor-
mal glycemia in the healthy population,
negatively impacting the general applica-
tion of the CGM technique and the ratio-
nal interpretation of the data obtained.
This multicenter study aims to generate
preliminary normal reference values for
CGM parameters using data collected
over 3 consecutive days in a sample of
healthy Chinese subjects.
RESEARCH DESIGN AND
METHODS— We enrolled Chinese
subjects from 10 academic hospitals in
China between October 2007 and July
2008. The inclusion criteria included the
following: 1) clinically stable condition
with no previous medical history of dia-
betes, hypertension, dyslipidemia, coro-
nary artery diseases, or cerebral stroke; 2)
fasting plasma glucose 100 mg/dl and
2-h plasma glucose (2-h PG) 140 mg/dl
after a 75-g oral glucose tolerance test
(OGTT),accordingto2008AmericanDi-
abetesAssociationdiabetesdiagnosticcri-
teria(7);3)normalBMIbetween18.5and
24.9 kg/m
2, according to 2004 World
Health Organization obesity diagnostic
criteria (8); 4) triglycerides 150 mg/dl
and HDL cholesterol 40 mg/dl, accord-
ing to 2007 Chinese guidelines on pre-
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(9);and5)systolicpressure140mmHg
and diastolic pressure 90 mmHg (10).
The exclusion criteria included the fol-
lowing: 1) use of medications that may
affect glucose metabolism, such as glu-
cocorticoids, thyroid hormones, and thi-
azide diuretics, 1 month before the study
and 2) hepatic or renal dysfunctions
(1.5-fold elevation of alanine amino-
transferase, aspartate aminotransferase,
or direct bilirubin or serum creatinine
115 mol/l). This study was indepen-
dently approved by the ethics committee
of each participant hospital. All subjects
gaveandsignedwritteninformedconsent
before study initiation. No accompanied
medications that adversely affect glucose
tolerance were allowed during the trial.
CGM
CGMsystem. TheCGMsystem(CGMS)
sensor (Medtronic, Northridge, CA) was
inserted into all subjects by the same spe-
cializednurseatday0at8:00–9:00 A.M.
inhospital.FirstCGMScalibrationbyﬁn-
ger stick blood glucose was performed af-
t e r1ho finitialization. If no abnormal
CGMS situation was observed, the sub-
jects were dismissed and continued with
CGM at home for 3 consecutive days.
Subjects were instructed to input at least
fourcalibrationreadingsperday.Atday3
at 8:00–9:00 A.M., subjects came to the
hospital and had the CGMS removed.
Adopted from previous established crite-
ria for optimal accuracy of the CGMS
(11,12), the following criteria for optimal
accuracy were adhered to: a correlation
between the sensor and meter readings of
at least 0.79 and a mean absolute differ-
ence of 28% (when the daily range
[min–max] of meter values was 100
mg/dl) and a mean absolute difference of
8%(whenthedailyrange[min–max]of
meter values was 100 mg/dl).
CGMparameters. The24-hmeanblood
glucose (24-h MBG) was calculated as
mean blood glucose level from 288 read-
ingsmeasuredbyaCGMSover24h.Day-
time and nighttime mean blood glucose
levelsweredeﬁnedasbloodglucoselevels
during the time intervals of 6:00 A.M.t o
10:00 P.M. and 10:00 P.M. to 6:00 A.M.,
respectively. Postprandial blood glucose
levelsat30,60,120,and180minandthe
area under the curve within 3 h after each
meal were recorded and calculated. For
eachsubject,theproportionoftimespent
on the blood glucose ranges of 70–140
(3.9–7.8mmol/l),140,and70mg/dl
weredeterminedfromtheCGMdata.Per-
centage of time (PT) for blood glucose
70 mg/dl and 140 mg/dl within 24 h
were recorded as PT70 and PT140, re-
spectively (13,14). Other CGM parame-
ters, including the area under the curve
forbloodglucose100mg/dlandtheSD
of blood glucose concentration within
24 h were also calculated (13,14). All of
the above parameters were based on the
mean values taken on days 1 and 2.
Mixed-meal method. All subjects re-
ceived dietary instructions according to
uniform criteria as the CGMS was imple-
mented. The total calorie intake from the
three daily meals was 30 kcal   kg
1  
day
1 during CGM, with 50% carbohy-
drates, 15% proteins, and 35% fats. The
amount of drinking water was not re-
stricted. The calorie distribution between
breakfast, lunch, and dinner was 20, 40,
and 40%, respectively. There was a disci-
plinary time of 6:30–7:30 A.M. for break-
fast, 11:30 A.M. to 12:30 P.M. for lunch,
and 6:00–7:00 P.M. for dinner. Each meal
had to be consumed within 30 min. Sub-
jects were required to follow the dietary
instruction during the CGM.
Laboratory examinations
Plasma glucose was determined using the
glucose oxidase method. Fully automatic
biochemistry analyzer (Hitachi 7600-
020; Hitachi, Tokyo, Japan) (enzymatic
methods) was used to determine hepatic
and renal function, triglycerides, and
HDL,LDL,andtotalcholesterol.Surestep
blood glucose meter (American Lifescan)
was used to determine ﬁnger stick capil-
lary blood glucose.
Statistical methods
CGM parameters were analyzed using
CGMS software 3.0. Measurement data
was presented as means  SD. Statistical
analyses were performed using SPSS soft-
ware (version 13.0). The t test was used
for comparison between two groups
when data were normally distributed;
otherwise, nonparametric analysis was
applied.PearsonandSpearmananalytical
methods were employed for correlation
analysis of two variables.
RESULTS
Subject characteristics
This study screened 588 subjects, among
which 445 healthy subjects without re-
lated metabolic disorders were recruited
for CGM. Eleven subjects were excluded
for ﬁnal analysis due to the CGMS signal
interruption or not meeting the accuracy
requirements. None of the subjects com-
plained of discomfort, such as inﬂamma-
tion or allergy at the embedding sites.
Data from the remaining 434 subjects
(213menand221women)wereincorpo-
rated into the statistical analysis. The 434
subjectswere4314yearsold(means
SD), with a range in age from 20 to 69
years. Subject distribution among age-
groups was similar: 23.5% were 20–29,
20.7% were 30–39, 19.8% were 40–49,
18.4% were 50–59, and 17.6% were
60–69 years old. The mean BMI was
21.8  1.7 kg/m
2. Compared with
women,menhadhigherBMI,bloodpres-
sure (both systolic and diastolic), triglyc-
eride levels, and OGTT 30-min plasma
glucose (P  0.05) and lower levels of
HDL cholesterol and OGTT 3-h plasma
glucose (P  0.001) (Table 1).
Correlation analysis of interstitial
glucose values by CGM and
corresponding capillary blood
glucose
For 434 healthy subjects, a total of
379,308 CGM readings were obtained.
The averages of 3,697 interstitial glucose
values retrieved from the CGM and their
correspondingﬁngerstickcapillaryblood
glucose were 103  21 and 103  17
mg/dl, respectively, with a mean absolute
difference of 9.0  8.4%. Pearson corre-
lation analysis revealed a positive correla-
tionbetweenthesetwovalues(r0.822,
P  0.001).
Characteristics of glucose proﬁles in
healthy subjects by CGM
A glucose proﬁle using the 24-h mean
data from 434 subjects is shown in Fig. 1.
The 24-h MBG was 104  10 mg/dl
(5.770.57mmol/l),andtheareaunder
the curve for blood glucose 100 mg/dl
was 9.7  6.7 mg   dl
1   day
1. The
nighttime MBG was lower than the day-
time MBG by 9  7% (98.6  11.3 vs.
106.4  11.3 mg/dl, P  0.001). There
were similar MBG levels for men and
women (Table 1).
In 434 subjects, the daily blood glu-
cose varied from a mean minimum of
76.911.3mg/dltoameanmaximumof
144.223.2mg/dl.TheSDofbloodglu-
cosewas14.25.8mg/dl.Therewereno
signiﬁcant differences between men and
women for these parameters (Table 1).
Thepostprandialbloodglucoselevels
at 30, 60, 120, and 180 min after each
meal, as well as postprandial area under
the curve within 3 h, are listed in Table 2.
Postprandial blood glucose level at 60
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prandialtimepointsforallthreemeals.At
thetimepointsof120and180min,com-
parison between the meals revealed a sig-
niﬁcantly lower blood glucose level after
breakfast than after lunch and dinner, re-
spectively (P  0.05). No signiﬁcant dif-
ferences were observed between blood
glucose levels after lunch and after
dinner.
Fluctuation of blood glucose within
70–140 mg/dl accounted for 93  8% of
the total day for the 434 subjects. PT140
and PT70 were 4.1  5.8% and 2.4 
5.3%, respectively. Approximately 60%
of subjects (n  260) experienced blood
glucose140mg/dl,withapercentageof
cumulative time duration of 6.8  6.1%.
Eight subjects (1.8%) experienced blood
glucose 200 mg/dl, with the longest ep-
isodelasting45min.Thecumulativetime
of blood glucose 200 mg/dl for these
subjects was 37  18 min. Blood glucose
70 mg/dl was detected in 176 (41%)
subjects and blood glucose 50 mg/dl in
24 subjects (5.5%). The cumulative time
durationforbloodglucose70mg/dlac-
counted for 5.9  7.0% of the day, and
the cumulative time for blood glucose
50 mg/dl was 30  26 min, lasting for
5–30 min each episode.
In all subjects, the distributions of
24-h MBG, PT140, and PT70 departed
from normality. The coefﬁcients of skew-
ness for these parameters were 0.252,
1.785, and 3.673, respectively. The 95th
percentiles of 24-h MBG, PT140, and
PT70 were set as reference values, with
the upper limit of 119 mg/dl (6.61
mmol/l)for24-hMBG,17.1%forPT140,
and 11.7% for PT70 (Table 3).
CGM parameters in relation to sex
and age
While both the 24-h MBG and PT140
showed a sex-independent weak positive
correlation with age (r  0.243, 0.277;
P0.001;r0.251,0.175;P0.009),
the PT70 did not (P  0.05). Analyses for
different age-groups revealed an in-
creased 24-h MBG level for men aged
40 years (P  0.01) and for women
aged 60 years (P  0.01). PT140 in-
creased in subjects aged 60 years for
both sexes (P  0.01). There was no sig-
niﬁcant difference for PT70 among the
age-groups(P0.05).Nosigniﬁcantdif-
ferencebetweenmenandwomenwasob-
served within any of the age-groups (P 
0.05) (Table 3).
Reproducibility of CGM evaluation
Reproducibility of CGM was evaluated in
a subgroup of 20 subjects, of which two
menandtwowomenfromeachoftheﬁve
age-groups (20–29, 30–39, 40–49, 50–
59, and 60–69 years) were randomized.
A 3-day CGM was repeated on these sub-
jects8–12weeksaftertheinitialmeasure-
ments. The 20 subjects were aged 43 
16 years (range 22–68), with a BMI of
22.2  1.8 kg/m
2. No signiﬁcant differ-
Figure 1—Continuous glucose proﬁles representing mean data from 24 h of monitoring in 434
healthy subjects. The center line is the mean, the next two outer lines represent the 5th and 95th
percentiles(P5andP95,respectively).Thearrowsindicatethetimeforthreemealintakesduring
a day.
Table 1—Characteristics of subjects by sex
Men Women P
n 213 221 NA
Age (years) 43  14 42  14 0.569
BMI (kg/m
2) 22.1  1.7 21.5  1.7 0.001*
Systolic blood pressure (mmHg) 117  10 111  13 0.001*
Diastolic blood pressure (mmHg) 76  67 1  8 0.001*
Total cholesterol (mg/dl) 174  31 178  35 0.171
Triglycerides (mg/dl) 93  32 87  32.8 0.038*
HDL cholesterol (mg/dl) 57  14.3 64  15.9 0.001*
LDL cholesterol (mg/dl) 105  29.0 104  35.2 0.854
Fasting plasma glucose (mg/dl) 86.4  7.7 86  7.9 0.682
OGTT 30-min plasma glucose (mg/dl) 145  29.3 134.1  26.1 0.001*
OGTT 1-h plasma glucose (mg/dl) 124  38.5 118.1  33.8 0.084
OGTT 2-h plasma glucose (mg/dl) 94  21.1 98.1  19.3 0.061
OGTT 3-h plasma glucose (mg/dl) 71  15.8 74.4  16.8 0.045*
MBG (mg/dl)
24 h 104  10.8 103.9  9.9 0.854
Daytime 106  11.5 106.6  11.2 0.853
Nighttime 99  11.9 98.3  10.6 0.518
Percentage of time at glycemia (%)
Blood glucose 140 mg/dl 4.2  5.9 4.0  5.7 0.612
70  blood glucose  140 mg/dl 93  89 4  7 0.550
Blood glucose 70 mg/dl 2.7  6.1 2.1  4.4 0.987
Area under the curve for blood
glucose 100 mg/dl (mg   dl
1  
day
1) 10.1  6.8 9.5  6.5 0.471
SD of blood glucose (mg/dl) 14.2  5.9 14.2  5.8 0.928
Max blood glucose (mg/dl) 144.2  23.8 144.2  22.9 0.972
Min blood glucose (mg/dl) 77.2  11.9 76.5  11.0 0.754
Data are mean  SD. *Signiﬁcant difference between men and women (P  0.05). NA, not applicable.
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ments taken at the two time periods for
any of the parameters. The values ob-
tained for the two measurements were
103.7  10.8 mg/dl for 24-h MBG, 2.6 
3.8% for PT140, and 0.7  1.1% for
PT70 at the ﬁrst session and, correspond-
ingly, 106  11.5 mg/dl, 3.8  5.7%,
and1.3 2.3%,respectively,atthesec-
ond session (P  0.05 for all three
parameters).
CONCLUSIONS — The CGM tech-
nique, using interstitial ﬂuid for glucose
determination (15), provides continuous
informationondynamicchangesinasub-
ject’s blood glucose levels. The current
study offers an opportunity to document
the typical glycemic patterns in a large
sample of continuously monitored
healthy Chinese subjects, which provides
a feasible and timely approach to obtain-
ing reference values. Considering the dis-
tribution of certain parameters in people
withoutdiabetesasastartingpointforthe
analysis, the study used means  2S Do r
95th percentile (for deﬁning normality)
to obtain a normal reference value. This
proposal has been applied for determina-
tion of physiological parameters such as
ambulatory blood pressure (16,17). Dif-
ferent from reference data derived from
epidemiologic studies of large popula-
tions (18), the present study completed
glucose measurement under routine liv-
ing conditions, generating a more precise
portrayal of typical daily glucose patterns
of normal individuals.
The results of this study most likely
reﬂect typical glycemic patterns for
healthy subjects. The 24-h MBG of 434
subjects between ages 20 and 69 years
was104mg/dl,aﬁndingcomparablewith
a recently reported 28-day CGM MBG
(102 mg/dl) obtained from 32 healthy
subjects using FreeStyle Navigator CGMS
(19). Postprandial blood glucose level at
60 min was higher than 30, 120, and 180
minforallthreemeals.Generally,theglu-
cose level after breakfast was lower than
lunch or dinner, which might be closely
related to the dietary structure and eating
habits. In our study, more than half of the
subjectsexperiencedbloodglucose140
mg/dl, and 41% subjects experienced
blood glucose 70 mg/dl. Similar glyce-
mic excursions have also been reported
by Mazze et al. (19) in subjects with nor-
mal glucose tolerance. The values for
PT140 and PT70 obtained were 4  4%
and 3  3%, respectively, while in our
study they were correspondingly 4.1 
5.8% and 2.4  5.3%, respectively. On
average, healthy subjects had a daily
blood glucose that ﬂuctuated within the
rangeof70–140mg/dlfor93%oftheday
in the present study.
CGM parameters provide general in-
formation on overall blood glucose levels
and blood glucose stability. The 24-h
MBG indicates glycemic control. Post-
prandial blood glucose levels, as well as
percentage of time in hypoglycemia or
hyperglycemia, provide the variability
in glycemic characteristics (19). In the
present study, the 95th percentile val-
ues for 24-h MBG, PT140, and PT70
were adopted as the upper normal lim-
its, since all three parameters were non-
normally distributed. The upper 95%
conﬁdence boundary for 24-h MBG was
Table 2—Postprandial blood glucose characteristics after three meals in 434 healthy subjects
Breakfast Lunch Dinner
Postprandial blood glucose 30 min (mg/dl) 114.3  15.6 117.2  18.9 116.6  17.8
Postprandial blood glucose 60 min (mg/dl) 121.1  21.3 121.7  20.9 123.1  26.1
Postprandial blood glucose 120min (mg/dl) 104.8  18.0 115.6  22.3* 119.7  21.2*
Postprandial blood glucose 180min (mg/dl) 97.6  17.6 109.3  17.3* 114.1  18.1*
Postprandial area under the curve within 3 h
(mg   dl
1   h
1) 327.3  38.7 340.6  47.4* 348.7  51.5*
Data are means  SD. For each parameter, *P  0.05 vs. blood glucose level after breakfast.
Table 3—Twenty-four-hour MBG and percentage of time at glycemia by sex and age
Men Women
All subjects
Aged 20–39
years
Aged 40–59
years
Aged 60–69
years All
Aged 20–39
years
Aged 40–59
years
Aged 60–69
years All
n 93 80 40 213 99 86 36 221 434
MBG (mg/dl) 101.3  10.8 105.3  10.1 107.3  10.4 104.4  10.8 101.3  9.2 103.9  10.4 109.3  9 103.7  9.9 103.9  10.3
P5 82.3 85.7 88.4 84.2 84.6 83.2 95.2 84.6 84.6
P10 85.7 89.3 95.4 88.2 86.4 89.6 97.2 90.2 89.1
P50 102.6 106.6 108 104.4 102.6 104.4 111.2 103.5 104.4
P90 116.1 117 119.5 117 111.6 117.9 121.0 117 117
P95 118.1 122.4 124.2 120.6 115.2 118.8 123.1 118.8 119.0
PT140 (%) 3.12  4.96 4.24  5.98 6.50  7.08 4.17  5.89 2.93  4.47 3.80  5.15 7.40  8.05 4.0  5.75 4.08  5.76
P 5 00 0 00 0 00 0
P 1 0 00 0 00 0 00 0
P50 0.50 1.75 5.5 1.50 0.50 1.5 5.75 1.00 1.0
P90 9.30 13.0 17.0 12.8 9.0 11.4 21.3 12.5 12.5
P95 14.0 17.5 24.0 17.0 11.5 14.8 22.6 19.0 17.1
PT70 (%) 3.68  7.25 1.60  4.81 2.50  4.95 2.68  6.07 1.87  3.59 2.40  5.61 2.01  3.42 2.10  4.46 2.38  5.31
P 5 00 0 00 0 00 0
P 1 0 00 0 00 0 00 0
P 5 0 00 0 00 0 00 0
P90 9.3 3.95 10.9 9.0 6.0 7.2 9.10 7.00 8.0
P95 14.0 8.90 14.4 12.0 11.5 14.0 11.2 11.0 11.6
Data are means  SD or percentile values.
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was 17% (4 h), and for PT70 was
12% (3 h). Moreover, CGM measure-
ments showed a favorable short-term
reproducibility in one subgroup of
healthy subjects. We found an excellent
complianceofﬁngerstickbloodglucose
with CGM measurements in this study.
Establishment of the normal reference
values may therefore provide important
evidence for clinical determination of
glucosemetabolicdisturbanceandeval-
uation of diabetic therapeutic effects.
As indicated by evaluation of the re-
lationshipbetweenCGMparameterswith
age and sex in this study, continuous
blood glucose levels are independent of
sex but increase with age. There was a
signiﬁcant increase in 24-h MBG in men
aged 40 years and women aged 60
years. We also recommend a uniﬁed cut-
off point for the normal reference values
of the CGM parameters, similar to the
normal glucose tolerance cutoff points
recommended by the American Diabetes
Association (7) or World Health Organi-
zation (20) without differentiating age
or sex.
To our knowledge, this is the ﬁrst
multicenter study conducted that at-
tempts to establish normal reference
valuesforCGMparametersinaChinese
population. The operation consistency
was well controlled by distributing uni-
form guidelines to each center and pro-
viding intensive subject education. The
use of data from centers in different re-
gions limits the potential for sample
bias, which could be considered to en-
hance the validity of the results. How-
ever, it still has to be interpreted within
the context of its limitations. This study
does not cover age-groups other than
ages 20–69 years. On the other hand, a
cross-sectional study for determination
of normal reference values requires a
larger sample size and more geographic
representations. Furthermore, the nor-
mal reference values of continuous
blood glucose parameters established in
this study need to be veriﬁed by future
prospective follow-up studies.
There is an increasing demand for
data that are able to capture both nor-
mal and abnormal blood glucose char-
acteristics, due to the recent trend of
reevaluation of blood glucose control in
terms of diabetes complication–related
factors such as blood glucose exposure,
stability, and variability (21,22). CGM,
by providing patterns of blood glucose
ﬂuctuations, meets this demand in clin-
ical practice. The reported reference
ranges for CGMS in a normal adult pop-
ulationcanbeusedtoaiddiabetesman-
agement and to create a baseline for
health monitoring. Future studies that
explicitly deﬁne normal and abnormal
CGMS parameter ranges in relation to
resulting pathology would supplement
this statistical deﬁnition and enable cli-
nicians to better utilize CGM informa-
tion to aid them in making therapeutic
regimen adjustments.
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